Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. (DAWN) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 331 transactions totaling $162.8M, demonstrating a bullish sentiment with $17.5M in net insider flow. The most recent transaction on Nov 25, 2025 involved a transaction of 7,225 shares valued at $0.
DAWN Insider Activity Summary
Who Is Buying DAWN Stock?
No significant insider buying has been recorded for DAWN in the recent period.
Who Is Selling DAWN Stock?
No significant insider selling has been recorded for DAWN in the recent period.
Is Day One Biopharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DAWN is bullish with an Insider Alignment Score of 55/100 and a net flow of $17.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
DAWN Frequently Asked Questions
Understanding DAWN Insider Activity
Insider trading at Day One Biopharmaceuticals, Inc. (DAWN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading DAWN stock, having executed 331 transactions in the past 90 days. The most active insider is Len Blavatnik (Executive), who has made 2 transactions totaling $28.0M.
Related Tools
Track Day One Biopharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at DAWN file new Form 4 transactions